F H Amante|M F Good - JoVE Visualize

Showing results (111-120 of 134) with videos related to

Pageof 14

Sort By:

Peptide Research|January 1, 1996

Mapping a conserved conformational epitope from the M protein of group A streptococciW A Relf, J Cooper, E R Brandt, et al.

Parasite Immunology|October 10, 1998

Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in miceC Hirunpetcharat, D Stanisic, X Q Liu, et al.

Nature Medicine|March 31, 2000

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal populationE R Brandt, K S Sriprakash, R I Hobb, et al.

Science (New York, N.Y.)|October 28, 1988

Limited immunological recognition of critical malaria vaccine candidate antigensM F Good, L H Miller, S Kumar, et al.

The Journal of Experimental Medicine|March 1, 1990

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytesW R Weiss, S Mellouk, R A Houghten, et al.

Nature Medicine|October 15, 1998

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challengeA D Hislop, M F Good, L Mateo, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988

Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the moleculeM F Good, D Pombo, I A Quakyi, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987

In vivo testing of subunit vaccines against malaria sporozoites using a rodent systemA A Lal, V F de la Cruz, M F Good, et al.

Science (New York, N.Y.)|February 27, 1987

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite proteinM F Good, W L Maloy, M N Lunde, et al.

Vaccine|June 12, 2003

CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based MontanidesC Hirunpetcharat, J Wipasa, S Sakkhachornphop, et al.

Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:

Pageof 14

Peptide Research|January 1, 1996

Mapping a conserved conformational epitope from the M protein of group A streptococciW A Relf, J Cooper, E R Brandt, et al.

Parasite Immunology|October 10, 1998

Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in miceC Hirunpetcharat, D Stanisic, X Q Liu, et al.

Nature Medicine|March 31, 2000

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal populationE R Brandt, K S Sriprakash, R I Hobb, et al.

Science (New York, N.Y.)|October 28, 1988

Limited immunological recognition of critical malaria vaccine candidate antigensM F Good, L H Miller, S Kumar, et al.

The Journal of Experimental Medicine|March 1, 1990

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytesW R Weiss, S Mellouk, R A Houghten, et al.

Nature Medicine|October 15, 1998

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challengeA D Hislop, M F Good, L Mateo, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988

Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the moleculeM F Good, D Pombo, I A Quakyi, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987

In vivo testing of subunit vaccines against malaria sporozoites using a rodent systemA A Lal, V F de la Cruz, M F Good, et al.

Science (New York, N.Y.)|February 27, 1987

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite proteinM F Good, W L Maloy, M N Lunde, et al.

Vaccine|June 12, 2003

CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based MontanidesC Hirunpetcharat, J Wipasa, S Sakkhachornphop, et al.

Pageof 14